This biotech company focuses on the discovery and development of promising molecule targets for immune-oncology therapy or targeted cancer therapy. Their pipeline includes drugs for autoimmune diseases, inflammations, syndromes, cardiac arrhythmia, and respiratory therapy.
| Contact Details | 5F, Building 1, Pangyo-ro 289beon-gil 20, Tel +82-31-698-3772E-mail bsc@bisichem.com |
|---|
